| abstract |
(57) [Summary]nThe present invention provides (-)-cis-6-phenyl-5- (4- (2-pyrrolidin-1-yl-ethoxy) -phenyl) -5,6,7,8-tetrahydronaphthalen-2-ol or the aforementioned Pharmaceutical compositions and methods comprising a pharmaceutically acceptable salt of a substance and parathyroid hormone or a biologically active fragment of said substance, methods of using such compositions, and methods of using such compositions. A kit containing the composition. The pharmaceutical composition of the present invention is useful for treating osteoporosis, osteoporotic fracture, low bone mass, and musculoskeletal fragility including bone fragility. |